All stock lists
Autolus Therapeutics plc (NASDAQ:AUTL)
GB · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.53-0.01 (-0.65%)
Insider Score
––Not scored
AUTL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AUTL Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 45.69 M | 26.22 M | 24.25 M | 21.19 M | 20.92 M | 8.98 M |
| Revenue Growth (YoY) | 118.37 % | 191.89 % | 83534.17 % | — | — | -10.99 % |
| Cost of Revenue | 20.47 M | 24.57 M | 25.29 M | 28.64 M | 24.45 M | 17.95 M |
| Gross Profit | 25.22 M | 1.65 M | -1.04 M | -7.45 M | -3.52 M | -8.97 M |
| SG&A Expense | 41.16 M | 39.95 M | 35.74 M | 36.28 M | 30.27 M | 29.53 M |
| R&D Expense | 27.90 M | 21.21 M | 35.58 M | 27.89 M | 27.43 M | 26.73 M |
| Operating Expenses | 69.06 M | 61.16 M | 71.32 M | 64.17 M | 57.70 M | 56.27 M |
| Operating Income | -43.84 M | -59.51 M | -72.36 M | -71.62 M | -61.22 M | -65.24 M |
| Pretax Income | -38.65 M | -70.73 M | -91.38 M | -78.59 M | -47.52 M | -67.94 M |
| Tax Provision | 465.00 K | 861.55 K | -1.18 M | 532.00 K | 397.00 K | 2.23 M |
| Net Income | -39.11 M | -71.60 M | -90.20 M | -79.12 M | -47.92 M | -70.16 M |
| EPS (Basic) | -0.15 | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| EPS (Diluted) | -0.15 | -0.27 | -0.34 | -0.30 | -0.18 | -0.26 |
| Shares Outstanding | 266.16 M | 266.14 M | 266.14 M | 266.14 M | 266.14 M | 266.13 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.